Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,594,464
+$1,522,870 QoQ
Shares Held
39,127
+1.6% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#184
of 768 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026First Financial Bankshares Inc holds $18,092,096 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (36.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
21,220 | $11,497,632 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
39,127 | $6,594,464 |
All Filings in NBIX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,594,464 | 39,127 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $5,071,594 | 38,497 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,368,690 | 37,853 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,990,441 | 28,426 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $3,591,968 | 28,578 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,071,472 | 27,771 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,677,583 | 26,942 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,043,311 | 17,734 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $2,295,784 | 16,676 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,233,338 | 16,193 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,082,071 | 15,802 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||